Ginkgo Bioworks Q1 2024 Update Business Review

Loading viewer...

earnings

Format: PDF earnings

Ginkgo Bioworks' Q1 2024 business review covering operational updates, financial outlook, and strategic initiatives including site consolidation and workforce adjustments. The presentation details progress toward adjusted EBITDA breakeven, Biofab1 opening timeline, and expansion of biodefense capabilities through the bioradar network and AI tools development.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Ginkgo Bioworks

View all →

Ginkgo Bioworks Q2 2022 Business Review & Update

investor_presentation

40 Pages

Similar earningss from other companies

Browse all →

ZF Friedrichshafen FY 2021 Investor Analyst Call

earnings

31 Pages

ZF Friedrichshafen AG

Brown-Forman 2Q17 1H17 Earnings Results December 2016

earnings